Finally, recurrent epigenetic silencing of DNAJC15/MCJ in NGSCTs makes these genes candidate predictive markers, because their expression in breast and uterine cancer cells is reportedly associated with drug resistance (Fernández-Cabezudo et al., 2016). The gene discussed is DNAJC15; the disease is uterine cancer.